Faculty & Staff
Mei-Ping Kung
Adjunct Associate Professor of Radiology
Department: Radiology
Contact information
HUP - 1 Silverstein
3400 SPRUCE ST.
4283
Philadelphia, PA 19104
3400 SPRUCE ST.
4283
Philadelphia, PA 19104
Office: 2156623096
Education:
B.S. (Agricultural Chemistry)
National Taiwan University, 1972.
M.S. (Biochemical Pharmacology)
State University of New York at Buffalo, 1975.
Ph.D. (Biochemistry, Pharmacology)
State University of New York at Buffalo , 1982.
B.S. (Agricultural Chemistry)
National Taiwan University, 1972.
M.S. (Biochemical Pharmacology)
State University of New York at Buffalo, 1975.
Ph.D. (Biochemistry, Pharmacology)
State University of New York at Buffalo , 1982.
Post-Graduate Training
Senior Research Assistant, Department of Pediatrics, Children's Hospital,State University of New York at Buffalo , 1977-1978.
Research Assistant, Department of Biochemical Pharmacology, State University of New York at Buffalo, 1978-1982.
Postdoctoral Pharmacologist, Department of Nuclear Medicine, State University of New York at Buffalo, 1987-1985.
Permanent linkSenior Research Assistant, Department of Pediatrics, Children's Hospital,State University of New York at Buffalo , 1977-1978.
Research Assistant, Department of Biochemical Pharmacology, State University of New York at Buffalo, 1978-1982.
Postdoctoral Pharmacologist, Department of Nuclear Medicine, State University of New York at Buffalo, 1987-1985.
Description of Research Expertise
Ligand Development and Characterization in NeuroscienceDescription of Other Expertise
Analytical Method DevelopmentSelected Publications
Zhuang ZP, Kung MP, Hou C, Plössl K, Kung HF: Biphenyls labeled with 99mTc for imaging Aß plaques in the brain Nuclear Medicine Biology. Elsevier, 32(2): 171-84, February 2005.Ono M, Haratake M, Nakayama M, Kaneko Y, Kawabata K, Mori H, Kung MP and Kung HF: Synthesis and Biological Evaluation of (E)-3-Styrylpyridine Derivatives as Amyloid Imaging Agents for Alzheimer’s Disease. Nuclear Medicine Biology Elsevier, 32(4): 329-35, May 2005.
Kung MP, Choi SR, Hou C, Zhuang ZP, Foulon C, Kung HF: Selective binding of 2-[125 I]iodo-nisoxetine to norepinephrine transporters in the brain. Nuclear Medicine and Biology 31(5): 533-41, July 2004.
Kung MP, Hou C, Zhuang ZP, Cross AJ, Maier DL, Kung HF : Characterization of IMPY as a potential imaging agent for ß-amyloid plaques in double transgenic PSAPP mice. European Journal of Nuclear Medicine and Molecular Imaging 31(8): 1136-45, August 2004 Notes: Epub 2004 Mar 9.
Kung MP, Hou C, Zhuang ZP, Skovronsky D, Kung HF: Binding Of Two Potential Imaging Agents Targeting Amyloid Plaques In Postmortem Brain Tissues Of Patients With Alzheimer's Disease. Disease. Brain Res. Elsevier, 1025: 98-105, September 2004.
Verhoeff NPLG, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, Kung HF, Kung MP, Houle S. : In vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. American Journal of Geriatric Psychiatry 12: 584-595, 2004.
Kung HF, Kung MP, Zhuang ZP, Hou C, Lee CW, Plössl K, Zhuang B, Skovronsky DM, Lee V, Trojanowski JQ. : Iodinated tracers for imaging amyloid plaques in the brain. Molecular Imaging and Biology. Elsevier, 5(6): 418-426, 2003.
Crystal AS, Giasson BI, Crowe A, Kung MP, Zhuang ZP, Trojanowki JQ, Lee VMY: A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114. Journal of Neurochemistry. International Society for Neurochemistry, 86: 1359-1368, 2003.
Kung MP, Zhuang ZP, Hou C, Jin LW, Kung HF: Characterization of radioiodinated ligand binding to amyloid beta plaques. Journal of Molecular Neuroscience. Human Press, 20: 249-253, 2003.
Ono M, Wilson A, Nobrega J, Westaway D, Verhoeff P, Zhuang ZP, Kung MP, Kung HF: 11C-labeled stilbene derivates as Aß-aggregate-specific PET imaging agents for Alzheimer’s disease. Nuclear Medicine and Biology. Elsevier, 30: 565-571, 2003.
